Scope of the Guideline 1. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Developed in collaboration with the Society of Cardiovascular Anesthesiologists. Cir- culation. 2006;114:e84 231. 2. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521 643. 3. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused up- date of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiol- ogy/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159 95. 4. Hiratzka LF, Creager MA, Isselbacher EM, et al. Surgery for aortic dilatation in patients with bicuspid aortic valves: a statement of clarification from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;133:680 6. 5. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninva- sive evaluation of native valvular regurgitation: a report from the Ameri- can Society of Echocardiography. Developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303 71. 6. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocar- diography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echo- cardiogr. 2010;11:307 32. 7. Fuster V, Ryden LE, Cannom DS, et al. 